Correlation of baseline tumor burden with clinical outcome in melanoma patients treated with ipilimumab

Angelova-Toshkina, Daniela; Weide, Benjamin; Tietze, Lutz F. F.; Hebst, Michelle; Tietze, Julia K. K.

dc.contributor.author	Weide, Benjamin Matthias
dc.date.accessioned	2024-08-12T07:12:56Z
dc.date.available	2024-08-12T07:12:56Z
dc.date.issued	2024
dc.identifier.issn	0030-2414
dc.identifier.uri	http://hdl.handle.net/10900/156544
dc.language.iso	en	de_DE
dc.publisher	Basel : Karger	de_DE
dc.relation.uri	http://dx.doi.org/10.1159/000533504	de_DE
dc.subject.ddc	610	de_DE
dc.title	Correlation of baseline tumor burden with clinical outcome in melanoma patients treated with ipilimumab	de_DE
dc.type	Article	de_DE
utue.quellen.id	20240422000000_01472
utue.publikation.seiten	76-84	de_DE
utue.personen.roh	Angelova-Toshkina, Daniela
utue.personen.roh	Weide, Benjamin
utue.personen.roh	Tietze, Lutz F. F.
utue.personen.roh	Hebst, Michelle
utue.personen.roh	Tietze, Julia K. K.
dcterms.isPartOf.ZSTitelID	Oncology	de_DE
dcterms.isPartOf.ZS-Issue	1	de_DE
dcterms.isPartOf.ZS-Volume	102	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE